(Q36999874)

17 August 2017

1 reference

title

Clinical results of I(f) current inhibition by ivabradine (English)

1 reference

17 August 2017

1

Jean-Claude Tardif

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

67 Suppl 2

1 reference

17 August 2017

page(s)

35-41

1 reference

Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767002-00005

The contribution of the 'pacemaker' current (if) to generation of spontaneous activity in rabbit sino-atrial node myocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767002-00005

Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767002-00005

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

21 January 2018

1 reference

12 December 2020

Characterization of single pacemaker channels in cardiac sino-atrial node cells

1 reference

12 December 2020

Retarding effect of lowered heart rate on coronary atherosclerosis

1 reference

12 December 2020

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

1 reference

12 December 2020

Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients

1 reference

12 December 2020

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

1 reference

12 December 2020

Clinical implications of present physiological understanding of HRV components.

1 reference

12 December 2020

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension

1 reference

12 December 2020

Heart-rate profile during exercise as a predictor of sudden death

1 reference

12 December 2020

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

1 reference

12 December 2020

Long-term safety and efficacy of ivabradine in patients with chronic stable angina

1 reference

12 December 2020

Predictors of carotid stenosis in older adults with and without isolated systolic hypertension

1 reference

12 December 2020

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

1 reference

12 December 2020

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

12 December 2020

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

1 reference

12 December 2020

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

1 reference

12 December 2020

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on M

1 reference

12 December 2020

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in

1 reference

12 December 2020

Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly).

1 reference

12 December 2020

The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers

1 reference

12 December 2020

Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982

1 reference

12 December 2020

Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.

1 reference

12 December 2020

10.2165/00003495-200767002-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1011405498

0 references

1 reference